Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BETd-246 + BM-1197 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BETd-246 | BET-d246 | BRD2 Inhibitor 1 BRD3 Inhibitor 2 BRD4 Inhibitor 10 | BETd-246 is a small molecule that induces degradation of Brd2, Brd3, and Brd4 proteins, leading to apoptosis of tumor cells (PMID: 28209615, PMID: 30797188). | |
BM-1197 | BCL-XL inhibitor 14 BCL2 inhibitor 27 | BM-1197 is a dual inhibitor of BCL2 and BCL-XL, which may result in increased apoptosis and decreased tumor growth (PMID: 24901320, PMID: 31892356). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|